"10.1371_journal.pone.0114050","plos one","2015-01-27T00:00:00Z","Sharon C Yates; Amen Zafar; Erzsebet M Rabai; James B Foxall; Sheila Nagy; Karen E Morrison; Carl Clarke; Margaret M Esiri; Sharon Christie; A David Smith; Zsuzsanna Nagy","Neuropharmacology and Neurobiology, College of Medical and Dental Sciences, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, B15 2TT, United Kingdom; Department of Neuropathology, University of Oxford, Level 1, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom; OPTIMA, University of Oxford, Level 4, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom; Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, United Kingdom","Conceived and designed the experiments: ZN SCY ADS. Performed the experiments: SCY AZ EMR JBF SN. Analyzed the data: SCY ZN EMR AZ. Contributed reagents/materials/analysis tools: MME SC ADS KEM CC. Wrote the paper: SCY ZN ADS EMR AZ JBF KEM CC MME SC SN. Obtained funding: ZN KEM CC MME ADS.","The authors have read the journal’s policy and the authors of this manuscript have the following competing interests: AD Smith was a scientific consultant to CytOx, Ltd., at the time the study commenced. MM Esiri and Z Nagy are shareholders of CytOx, Ltd., (<1.5% each) and were consultants to the company at the time the study commenced. Z Nagy is the named inventor on the patent applications owned by the University of Oxford and the University of Birmingham. SC Yates, A Zafar, EM Rabai, J Foxall, S Nagy, S Christie, KE Morrison and C Clarke have declared that no competing interests exist. This does not alter the authors’ adherence to PLOS ONE policies on sharing data and materials.","2015","01","Sharon C Yates","SCY",11,FALSE,3,5,4,11,TRUE,TRUE,FALSE,0,NA,FALSE
